If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

van Apeldoorn FJ, van Hout WJPJ, Mersch PPA, Huisman M, Slaap BR, Hale WW III, Visser S, van Dyck R, den Boer JA. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia. Objective: 

To establish whether the combination of cognitive-behavioral therapy (CBT) and pharmacotherapy (SSRI) was more effective in treating panic disorder (PD) than either CBT or SSRI alone, and to evaluate any differential effects between the mono-treatments. Method: 

Patients with PD (n =150) with or without agoraphobia received CBT, SSRI or CBT + SSRI. Outcome was assessed after 9 months, before medication taper. Results: 

CBT + SSRI was clearly superior to CBT in both completer and intent-to-treat analysis (ITT). Completer analysis revealed superiority of CBT + SSRI over SSRI on three measures and no differences between CBT and SSRI. ITT analysis revealed superiority of SSRI over CBT on four measures and no differences between CBT + SSRI and SSRI. Conclusion: 

Both the mono-treatments (CBT and SSRI) and the combined treatment (CBT + SSRI) proved to be effective treatments for PD. At post-test, CBT + SSRI was clearly superior to CBT, but differences between CBT + SSRI and SSRI, and between SSRI and CBT, were small.

Keywords: agoraphobia; cognitive-behavioral therapy; drug treatment; panic disorder; randomized controlled trials

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0447.2008.01157.x

Affiliations: 1: University Medical Center Groningen 2: University of Groningen 3: Global Clinical Development, N.V. Organon, Oss 4: Utrecht University, Research Center Adolescent Development 5: VU University Medical Center, Amsterdam, the Netherlands

Publication date: April 1, 2008

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more